Home LiteratureArticle Details
PMID: 8625293 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Repair Defect in p21 WAF1/CIP1 -/- human cancer cells.

Cancer research ·Vol. 56 ·No. 10 ·1996-05-15 ·Pages 2250-5

McDonald ER, Wu GS, Waldman T, El-Deiry WS

Abstract

p53 induction and cell cycle arrest occur following DNA damage, possibly to allow repair prior to replication. p21WAF1/CIP1, a cyclin-cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen-interacting protein, is induced by p53 and mediates the cell cycle arrest. To investigate a role for p21 in DNA repair in vivo, we studied the expression of in vitro damaged reporter DNA transfected into p21 +/+ or -/- HCT116 human colon cancer cells. Introduction of UV-damaged or cisplatinum-damaged cytomegalovirus-driven beta-galactosidase reporter DNA into tumor cells revealed a significant decrease (2-5-fold) in reporter expression in p21 -/- versus +/+ cells. In the absence of DNA damage, there was a significant increase (2-3-fold) in the number of 6-TG-resistant colonies derived from p21 -/- versus +/+ cells. Reintroduction of wild-type p21, but not a p21 C-terminal truncation mutant which lacks the proliferating cell nuclear antigen interaction domain, stimulated (2-3-fold) the repair capacity of the p21-deficient cells. We conclude that p21 deficiency is associated with a defect in DNA repair, which could lead to an increased sensitivity of tumor cells to DNA damage.

MeSH Terms
Cell Cycle/genetics Cell Division Cisplatin/pharmacology Colonic Neoplasms/pathology Cyclin-Dependent Kinase Inhibitor p21 Cyclins/deficiency,genetics,physiology DNA Damage DNA Repair/genetics DNA Replication DNA, Neoplasm/drug effects,metabolism,radiation effects Genes, Reporter/drug effects,radiation effects Humans Neoplasm Proteins/deficiency,genetics,physiology Proliferating Cell Nuclear Antigen/metabolism Thioguanine/pharmacology Tumor Cells, Cultured Tumor Stem Cell Assay Tumor Suppressor Protein p53/physiology Ultraviolet Rays
Chemicals
CDKN1A protein, human Cyclin-Dependent Kinase Inhibitor p21 Cyclins DNA, Neoplasm Neoplasm Proteins Proliferating Cell Nuclear Antigen Tumor Suppressor Protein p53 Thioguanine Cisplatin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
McDonald E R
Howard Hughes Medical Institute, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania Comprehensive Cancer Center, Philadelphia, 19104, USA.
Wu G S
Waldman T
El-Deiry W S
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1996-05-15
Pages
2250-5
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NIGMS NIH HHS · 5-T32-GM08216 · United States
NIGMS NIH HHS · GM07309 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]